LeMaitre Vascular (LMAT) Short Interest Ratio & Short Volume $96.45 -0.26 (-0.27%) Closing price 04:00 PM EasternExtended Trading$96.51 +0.06 (+0.06%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LeMaitre Vascular Short Interest DataLeMaitre Vascular (LMAT) has a short interest of 1.33 million shares, representing 6.49% of the float (the number of shares available for trading by the public). This marks a -3.62% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.3, indicating that it would take 8.3 days of the average trading volume of 189,951 shares to cover all short positions.Current Short Interest1,330,000 sharesPrevious Short Interest1,380,000 sharesChange Vs. Previous Month-3.62%Dollar Volume Sold Short$108.05 millionShort Interest Ratio8.3 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares22,638,000 sharesShort Percent of Float6.49%Today's Trading Volume223,252 sharesAverage Trading Volume189,951 sharesToday's Volume Vs. Average118% Short Selling LeMaitre Vascular? Sign up to receive the latest short interest report for LeMaitre Vascular and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLMAT Short Interest Over TimeLMAT Days to Cover Over TimeLMAT Percentage of Float Shorted Over Time LeMaitre Vascular Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20251,330,000 shares $108.05 million -3.6%6.5%8.3 $81.24 7/15/20251,380,000 shares $113.48 million -5.5%N/A8.3 $82.23 6/30/20251,460,000 shares $121.25 million +11.5%7.1%8.1 $83.05 6/15/20251,310,000 shares $106.28 million +1.6%6.4%6.9 $81.13 5/31/20251,290,000 shares $106.00 million -0.8%6.4%6.1 $82.17 5/15/20251,300,000 shares $108.29 million +0.8%6.5%5.5 $83.30 4/30/20251,290,000 shares $117.05 million -1.5%6.3%5.5 $90.74 4/15/20251,310,000 shares $110.87 million +3.2%6.4%5.9 $84.63 3/31/20251,270,000 shares $106.55 million +8.6%6.2%5.8 $83.90 3/15/20251,170,000 shares $95.83 million +1.7%5.7%5.5 $81.91 Get the Latest News and Ratings for LMAT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LeMaitre Vascular and its competitors with MarketBeat's FREE daily newsletter. 2/28/20251,150,000 shares $105.63 million -8.0%5.6%5.6 $91.85 2/15/20251,250,000 shares $123.31 million -3.9%6.1%7.1 $98.65 1/31/20251,300,000 shares $126.01 million No Change6.4%8.1 $96.93 1/15/20251,300,000 shares $127.09 million +7.4%6.3%8 $97.76 12/31/20241,210,000 shares $111.49 million +37.5%5.9%7.7 $92.14 12/15/2024880,000 shares $88.61 million +4.5%4.3%5.9 $100.69 11/30/2024842,100 shares $90.10 million +11.3%4.1%7 $106.99 11/15/2024756,300 shares $77.16 million -3.6%3.7%6.5 $102.02 10/31/2024784,500 shares $69.34 million -32.4%3.8%6.9 $88.39 10/15/20241,160,000 shares $105.84 million -1.7%5.7%9.8 $91.24 9/30/20241,180,000 shares $109.61 million +15.7%5.8%9.2 $92.89 9/15/20241,020,000 shares $91.48 million -2.9%5.0%7.8 $89.69 8/31/20241,050,000 shares $94.80 million -4.6%5.1%7.9 $90.29 8/15/20241,100,000 shares $91.95 million +30.8%5.4%8 $83.59 7/31/2024840,700 shares $73.05 million +5.3%4.1%6.1 $86.89 7/15/2024798,400 shares $68.91 million 0.0%3.9%5.9 $86.31 6/30/2024798,700 shares $65.72 million +7.8%3.9%6.2 $82.28 6/15/2024740,700 shares $59.32 million +0.5%3.6%6 $80.09 5/31/2024737,300 shares $58.16 million -13.8%3.6%6.1 $78.88 5/15/2024855,500 shares $66.79 million -2.6%4.2%6.3 $78.07 4/30/2024878,700 shares $56.94 million +3.1%4.4%6.4 $64.80 4/15/2024852,100 shares $54.92 million +9.9%4.3%7.3 $64.45 3/31/2024775,200 shares $51.44 million -0.6%3.9%6.8 $66.36 3/15/2024780,100 shares $52.14 million +7.1%3.9%6.9 $66.84 2/29/2024728,600 shares $51.00 million -17.1%3.7%6.1 $70.00 2/15/2024879,200 shares $54.58 million -4.4%4.4%8.7 $62.08 1/31/2024919,700 shares $53.38 million -5.3%4.6%9.2 $58.04 1/15/2024971,400 shares $54.10 million +1.1%4.9%7.9 $55.69 12/31/2023960,600 shares $54.52 million +1.2%4.8%7.3 $56.76 12/15/2023948,800 shares $52.74 million -0.3%4.8%6.6 $55.59He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.See his full breakdown of the seven stocks to own now 11/30/2023951,800 shares $50.16 million -10.2%4.8%6.7 $52.70 11/15/20231,060,000 shares $55.28 million -11.7%5.4%7.8 $52.15 10/31/20231,200,000 shares $58.30 million +28.7%6.1%8.9 $48.58 10/15/2023932,400 shares $43.61 million +27.3%4.7%7.7 $46.77 9/30/2023732,500 shares $39.91 million +18.2%3.7%6.7 $54.48 9/15/2023619,500 shares $35.36 million +7.7%3.1%6.1 $57.08 8/31/2023575,400 shares $33.26 million -3.0%2.9%5.4 $57.81 8/15/2023593,200 shares $33.81 million +2.5%3.0%5.4 $56.99 7/31/2023578,900 shares $36.60 million -5.7%2.9%5 $63.23 7/15/2023614,000 shares $40.56 million +0.9%3.1%5 $66.06 6/30/2023608,300 shares $40.93 million -1.3%3.1%5.1 $67.28 6/15/2023616,200 shares $41.45 million +16.8%3.1%5.3 $67.26 5/31/2023527,500 shares $33.15 million -2.1%2.7%4.8 $62.84 5/15/2023538,900 shares $34.64 million -11.3%2.7%4.9 $64.27 4/30/2023607,400 shares $32.80 million -0.4%3.1%5.9 $54.00 4/15/2023609,900 shares $32.07 million +5.8%3.1%7.3 $52.59 3/31/2023576,500 shares $29.67 million -6.5%3.0%6.7 $51.47 3/15/2023616,400 shares $30.69 million +1.4%3.2%7.4 $49.79 2/28/2023608,000 shares $30.47 million +18.8%3.1%7.3 $50.11 2/15/2023511,600 shares $25.46 million +12.5%2.6%6.6 $49.77 1/31/2023454,800 shares $21.46 million -17.5%2.4%6.3 $47.18 1/15/2023551,100 shares $25.42 million -5.1%2.8%6.5 $46.13 12/30/2022580,600 shares $26.72 million +4.3%3.0%6.6 $46.02 12/15/2022556,700 shares $25.41 million -2.0%2.9%5.9 $45.65 11/30/2022568,000 shares $26.61 million +3.8%2.9%6.2 $46.85 11/15/2022547,300 shares $25.49 million -32.1%2.8%6 $46.57 10/31/2022806,200 shares $34.99 million -0.6%4.2%8.3 $43.40 10/15/2022811,000 shares $38.05 million -11.1%4.2%8.7 $46.92 9/30/2022912,500 shares $46.25 million +3.3%4.7%9.8 $50.68 9/15/2022883,400 shares $44.66 million -3.7%4.6%9.8 $50.56 8/31/2022917,300 shares $45.30 million -5.0%4.7%10.1 $49.38 8/15/2022965,100 shares $54.04 million -18.2%5.0%10 $55.99 7/31/20221,180,000 shares $59.41 million -1.7%7.4%10.9 $50.35 7/15/20221,200,000 shares $56.18 million +5.3%7.5%10.1 $46.82 6/30/20221,140,000 shares $51.93 million -4.2%7.2%8.8 $45.55 6/15/20221,190,000 shares $52.03 million +5.3%7.5%8.7 $43.72 5/31/20221,130,000 shares $51.66 million -5.0%5.9%7.8 $45.72 5/15/20221,190,000 shares $51.66 million +2.6%6.2%7.9 $43.41 4/30/20221,160,000 shares $50.12 million +0.9%6.0%8.6 $43.21 4/15/20221,150,000 shares $53.49 million +0.9%6.0%9.6 $46.51 3/31/20221,140,000 shares $52.98 million -4.2%5.9%10.8 $46.47 3/15/20221,190,000 shares $49.90 million +9.2%6.2%12.7 $41.93 2/28/20221,090,000 shares $51.74 million +3.8%5.7%11.7 $47.47 2/15/20221,050,000 shares $45.54 million +1.0%5.5%11.6 $43.37 1/31/20221,040,000 shares $44.00 million +2.0%5.4%11.4 $42.31 1/15/20221,020,000 shares $46.71 million +3.6%5.3%10.5 $45.79 12/31/2021984,600 shares $49.46 million +4.4%5.1%10.4 $50.23 12/15/2021943,000 shares $46.23 million -0.4%4.9%9.2 $49.02 11/30/2021946,500 shares $44.29 million +14.2%4.9%8.9 $46.79 11/15/2021829,200 shares $45.52 million -15.9%4.3%7.7 $54.90He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.See his full breakdown of the seven stocks to own now 10/29/2021985,800 shares $51.27 million -1.4%5.2%9.2 $52.01 10/15/20211,000,000 shares $53.58 million -23.1%5.3%9.6 $53.58 9/30/20211,300,000 shares $69.02 million +13.0%6.8%10.3 $53.09 9/15/20211,150,000 shares $66.10 million +10.6%6.0%8.2 $57.48 8/31/20211,040,000 shares $58.88 million -7.1%5.5%7.3 $56.62 8/13/20211,120,000 shares $61.84 million +6.7%5.9%7.8 $55.21 7/30/20211,050,000 shares $57.18 million -18.0%5.6%7.2 $54.46 7/15/20211,280,000 shares $69.54 million +2.4%6.8%8.5 $54.33 6/30/20211,250,000 shares $76.28 million -18.8%6.9%9.4 $61.02 6/15/20211,540,000 shares $90.97 million -7.2%8.5%12.8 $59.07 5/28/20211,660,000 shares $85.01 million +1.8%9.2%14.1 $51.21 5/14/20211,630,000 shares $79.28 million +8.0%9.0%12.8 $48.64 4/30/20211,510,000 shares $81.33 million -5.0%8.5%11.6 $53.86 4/15/20211,590,000 shares $79.36 million No Change8.9%12.6 $49.91 3/31/20211,590,000 shares $75.75 million +1.9%9.0%12.7 $47.64 3/15/20211,560,000 shares $75.04 million -10.3%8.8%12.1 $48.10 2/26/20211,740,000 shares $80.82 million +8.1%10.0%13.6 $46.45 2/12/20211,610,000 shares $76.52 million -14.4%9.3%13.4 $47.53 1/29/20211,880,000 shares $91.24 million -4.1%10.9%15.3 $48.53 1/15/20211,960,000 shares $84.81 million +7.7%11.4%16.1 $43.27 12/31/20201,820,000 shares $71.96 million +1.1%10.6%15.3 $39.54 12/15/20201,800,000 shares $62.08 million -2.2%10.4%14.6 $34.49 11/30/20201,840,000 shares $72.83 million No Change10.7%15.2 $39.58 11/15/20201,840,000 shares $68.45 million -3.7%10.7%15.9 $37.20 10/30/20201,910,000 shares $67.88 million -9.1%11.2%16.4 $35.54 10/15/20202,100,000 shares $68.71 million +1.5%12.4%18.6 $32.72 9/30/20202,070,000 shares $67.34 million +2.5%12.2%16.8 $32.53 9/15/20202,020,000 shares $64.92 million +4.1%11.9%15.4 $32.14 8/31/20201,940,000 shares $61.11 million -1.0%11.5%15.1 $31.50 LMAT Short Interest - Frequently Asked Questions What is LeMaitre Vascular's current short interest? Short interest is the volume of LeMaitre Vascular shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 1,330,000 shares of LMAT short. 6.49% of LeMaitre Vascular's shares are currently sold short. Learn More on LeMaitre Vascular's current short interest. What is a good short interest ratio for LeMaitre Vascular? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LMAT shares currently have a short interest ratio of 8.0. Learn More on LeMaitre Vascular's short interest ratio. What is a good short interest percentage for LeMaitre Vascular? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.49% of LeMaitre Vascular's floating shares are currently sold short. Is LeMaitre Vascular's short interest increasing or decreasing? LeMaitre Vascular saw a drop in short interest in the month of July. As of July 31st, there was short interest totaling 1,330,000 shares, a drop of 3.6% from the previous total of 1,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does LeMaitre Vascular's short interest compare to its competitors? 6.49% of LeMaitre Vascular's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to LeMaitre Vascular: Stevanato Group S.p.A. (4.09%), iRhythm Technologies (7.93%), Glaukos Corporation (7.07%), Bausch + Lomb Corporation (11.11%), Soleno Therapeutics, Inc. (13.56%), TransMedics Group, Inc. (24.19%), Envista Holdings Corporation (5.69%), LivaNova PLC (4.19%), Warby Parker Inc. (9.29%), Inspire Medical Systems, Inc. (8.85%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short LeMaitre Vascular stock? Short selling LMAT is an investing strategy that aims to generate trading profit from LeMaitre Vascular as its price is falling. LMAT shares are trading down $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against LeMaitre Vascular? A short squeeze for LeMaitre Vascular occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LMAT, which in turn drives the price of the stock up even further. How often is LeMaitre Vascular's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LMAT, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies STVN Short Interest Data IRTC Short Interest Data GKOS Short Interest Data BLCO Short Interest Data SLNO Short Interest Data TMDX Short Interest Data NVST Short Interest Data LIVN Short Interest Data WRBY Short Interest Data INSP Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LMAT) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LeMaitre Vascular, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LeMaitre Vascular With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access